FI932035A0 - Tricykliska foereningar innehaollande heteroatomer - Google Patents

Tricykliska foereningar innehaollande heteroatomer

Info

Publication number
FI932035A0
FI932035A0 FI932035A FI932035A FI932035A0 FI 932035 A0 FI932035 A0 FI 932035A0 FI 932035 A FI932035 A FI 932035A FI 932035 A FI932035 A FI 932035A FI 932035 A0 FI932035 A0 FI 932035A0
Authority
FI
Finland
Prior art keywords
heteroatomer
tricyclic
foereningar innehaollande
foereningar
innehaollande
Prior art date
Application number
FI932035A
Other languages
English (en)
Other versions
FI102612B (fi
FI932035A (fi
FI102612B1 (fi
Inventor
Karl Baumann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929209815A external-priority patent/GB9209815D0/en
Priority claimed from GB939304927A external-priority patent/GB9304927D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of FI932035A0 publication Critical patent/FI932035A0/fi
Publication of FI932035A publication Critical patent/FI932035A/fi
Priority to FI982476A priority Critical patent/FI982476A0/fi
Application granted granted Critical
Publication of FI102612B publication Critical patent/FI102612B/fi
Publication of FI102612B1 publication Critical patent/FI102612B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Saccharide Compounds (AREA)
FI932035A 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo[18.6.1.0 ]heptakoseenien ja niiden johdannaisten valmistamiseksi FI102612B1 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209815A GB9209815D0 (en) 1992-05-07 1992-05-07 Organic compounds,processes for their production and their use
GB939304927A GB9304927D0 (en) 1993-03-10 1993-03-10 Organic compounds

Publications (4)

Publication Number Publication Date
FI932035A0 true FI932035A0 (fi) 1993-05-05
FI932035A FI932035A (fi) 1993-11-08
FI102612B FI102612B (fi) 1999-01-15
FI102612B1 FI102612B1 (fi) 1999-01-15

Family

ID=26300836

Family Applications (2)

Application Number Title Priority Date Filing Date
FI932035A FI102612B1 (fi) 1992-05-07 1993-05-05 Menetelmä terapeuttisesti käyttökelpoisten trisyklo[18.6.1.0 ]heptakoseenien ja niiden johdannaisten valmistamiseksi
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI982476A FI982476A0 (fi) 1992-05-07 1998-11-16 Heteroatomeja sisältäviä trisyklisiä yhdisteitä

Country Status (25)

Country Link
US (1) US5514685A (fi)
EP (1) EP0569337B1 (fi)
JP (1) JP2788392B2 (fi)
KR (1) KR100292311B1 (fi)
CN (1) CN1037773C (fi)
AT (1) ATE155787T1 (fi)
AU (1) AU668152B2 (fi)
CA (1) CA2095659C (fi)
CY (1) CY2126B1 (fi)
CZ (1) CZ291773B6 (fi)
DE (1) DE69312386T2 (fi)
DK (1) DK0569337T3 (fi)
ES (1) ES2105193T3 (fi)
FI (2) FI102612B1 (fi)
GR (1) GR3024754T3 (fi)
HU (2) HUT66531A (fi)
IL (1) IL105607A (fi)
MY (1) MY109602A (fi)
NO (1) NO305865B1 (fi)
NZ (1) NZ247553A (fi)
PH (1) PH30456A (fi)
RU (1) RU2126009C1 (fi)
SG (1) SG47011A1 (fi)
SK (1) SK282061B6 (fi)
TW (1) TW330936B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY110603A (en) * 1993-05-27 1998-08-29 Novartis Ag Tetrahydropyran derivatives
GB2308546B (en) 1994-10-26 1999-06-02 Novartis Ag Topical macrolide compositions
IL115742A (en) 1994-10-26 2000-06-01 Novartis Ag Pharmaceutical compositions comprising a difficultly soluble active agent a hydrophilic phase a lipophilic phase and a surfactant
TWI235068B (en) 1998-03-26 2005-07-01 Fujisawa Pharmaceutical Co Sustained-release pharmaceutical composition
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
JP2005536516A (ja) 2002-07-23 2005-12-02 ノバルティス アクチエンゲゼルシャフト 薬剤、軟膏基剤および可溶化剤／分散剤を含む、眼科用軟膏組成物
KR100469917B1 (ko) * 2002-09-09 2005-02-02 (주)조은식품 구수한 호박씨가 첨가된 호박엿 및 그 제조방법
KR100745493B1 (ko) * 2005-12-16 2007-08-03 주식회사농심 조직감이 향상된 사출 스낵 및 그 제조 방법
JP5739517B2 (ja) * 2010-04-02 2015-06-24 ヤンセン・アールアンドデイ・アイルランド 大環状インテグラーゼ阻害剤
WO2016068208A1 (ja) 2014-10-28 2016-05-06 国立研究開発法人国立成育医療研究センター 妊娠状態を改善するための薬剤及びその利用
CN112533599A (zh) 2018-08-10 2021-03-19 山口晃史 与母体和胎儿的关系中的体液免疫相关的疾病的治疗药
JPWO2020129348A1 (ja) 2018-12-18 2021-11-04 晃史 山口 不妊・不育症または妊娠状態を改善するための薬剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5254562A (en) * 1984-12-03 1993-10-19 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
DE68904037T2 (de) * 1988-10-12 1993-06-03 Merck & Co Inc Verfahren zur umlagerung von fk-506 unter beteiligung von hydroxid.
CA1316916C (en) * 1988-10-12 1993-04-27 David Askin Hydroxide mediated fk-506 rearrangement product
JPH04500372A (ja) * 1989-06-14 1992-01-23 サンド・リミテッド 異種原子含有三環式化合物
EP0413532A3 (en) * 1989-08-18 1991-05-15 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506
GB2246350A (en) * 1990-07-23 1992-01-29 Fujisawa Pharmaceutical Co Tricyclo compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
WO1993004679A1 (en) * 1991-09-05 1993-03-18 Abbott Laboratories Macrocyclic immunomodulators

Also Published As

Publication number Publication date
FI102612B (fi) 1999-01-15
ES2105193T3 (es) 1997-10-16
CN1037773C (zh) 1998-03-18
FI932035A (fi) 1993-11-08
SK282061B6 (sk) 2001-10-08
DE69312386D1 (de) 1997-08-28
DK0569337T3 (da) 1998-01-19
IL105607A0 (en) 1993-09-22
ATE155787T1 (de) 1997-08-15
FI102612B1 (fi) 1999-01-15
CZ291773B6 (cs) 2003-05-14
SG47011A1 (en) 1998-03-20
FI982476A0 (fi) 1998-11-16
DE69312386T2 (de) 1998-01-29
CN1083486A (zh) 1994-03-09
MY109602A (en) 1997-03-31
NZ247553A (en) 1995-07-26
HU9301190D0 (en) 1993-07-28
US5514685A (en) 1996-05-07
JP2788392B2 (ja) 1998-08-20
CA2095659A1 (en) 1993-11-08
NO931627D0 (no) 1993-05-05
KR940005631A (ko) 1994-03-22
EP0569337A1 (en) 1993-11-10
CZ82993A3 (en) 1994-01-19
PH30456A (en) 1997-05-28
HUT66531A (en) 1994-12-28
SK43593A3 (en) 1995-07-11
AU3839393A (en) 1993-11-11
CA2095659C (en) 2005-08-09
EP0569337B1 (en) 1997-07-23
JPH0641144A (ja) 1994-02-15
IL105607A (en) 1998-01-04
TW330936B (en) 1998-05-01
NO305865B1 (no) 1999-08-09
GR3024754T3 (en) 1997-12-31
AU668152B2 (en) 1996-04-26
NO931627L (no) 1993-11-08
KR100292311B1 (ko) 2001-09-17
CY2126B1 (en) 2002-06-21
RU2126009C1 (ru) 1999-02-10
HU211135A9 (en) 1995-10-30

Similar Documents

Publication Publication Date Title
DE69319976T2 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
TW269678B (fi)
MX9304646A (es) Nuevas 7-(sustituido)-8-(sustituido)d-9-[(glicilo sustituido)amido]-6-desmetil-6-desoxitetraciclinasy metodo para su produccion.
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
DK0618190T3 (da) 9-(Substitueret glycyl)amido-6-(substitueret)-5-hydroxy-6-deoxy-tetracycliner
FI932035A (fi) Tricykliska foereningar innehaollande heteroatomer
PT626385E (pt) Derivados do tetra-hidropirano
DE69419661T2 (de) Thiazolotriazol- und Thiazolodiazolderivate mit fungizider Aktivität
NO178540C (no) Bisfenyletanderivater, farmasöytisk preparat derav samt anvendelse
DE69313931D1 (de) Polycyclische 31668P- und 31668U-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als antibiotische oder antitumorale Arzneistoffe
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer

Legal Events

Date Code Title Description
FG Patent granted

Owner name: NOVARTIS AG

GB Transfer or assigment of application

Owner name: NOVARTIS AG

MM Patent lapsed